Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

SHSE:600329 Stock Report

Market Cap: CN¥22.3b

Tianjin Pharmaceutical Da Ren Tang Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Lei Wang

Chief executive officer

CN¥2.6m

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenure2.4yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

Are Investors Undervaluing Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) By 48%?

Oct 27
Are Investors Undervaluing Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) By 48%?

Why Investors Shouldn't Be Surprised By Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) 36% Share Price Surge

Oct 08
Why Investors Shouldn't Be Surprised By Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) 36% Share Price Surge

Some Shareholders Feeling Restless Over Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) P/E Ratio

Jul 26
Some Shareholders Feeling Restless Over Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) P/E Ratio

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Jul 05
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Apr 18
Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Mar 18
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

CEO

Lei Wang (53 yo)

2.3yrs

Tenure

CN¥2,625,100

Compensation

Ms. Lei Wang serves as Executive Director of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited since December 30, 2022 and serves as its General Manager since August 22, 2022. She served as Gene...


Leadership Team

NamePositionTenureCompensationOwnership
Lei Wang
GM & Executive Director2.3yrsCN¥2.63mno data
Jian Ma
Chief Financial Officer1.3yrsCN¥190.30kno data
Hong Zhou
Deputy GM5.5yrsCN¥1.38m0.0031%
CN¥ 690.2k
Min Guo
Executive Directorno datano datano data
Yu Zhang
Chief Manufacturing Officer2.6yrsCN¥893.80kno data
Mingjie Shang
Executive Directorless than a yearCN¥299.00kno data
Yan Jiao
Secretary to the Board of Directors16.9yrsCN¥445.80k0.0013%
CN¥ 294.9k

2.4yrs

Average Tenure

53yo

Average Age

Experienced Management: 600329's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lei Wang
GM & Executive Director1.9yrsCN¥2.63mno data
Hong Zhou
Deputy GM5.5yrsCN¥1.38m0.0031%
CN¥ 690.2k
Min Guo
Executive Director3.3yrsno datano data
Mingjie Shang
Executive Director1.4yrsCN¥299.00kno data
Yoke Pheng Liew
Independent & Non-Executive Director4.4yrsCN¥259.16kno data
Yuanxia Wang
Chairman of Board of Supervisors4.9yrsno datano data
Jianhua Xing
Supervisor2.9yrsno datano data
Mingrui Zhang
Non-Executive & Non-Independent Chairman2.9yrsno datano data
Weiwen Mao
Non-Executive Non-Independent Director1.9yrsno datano data
Guat Kwang Yeo
Lead Independent Directorless than a yearno datano data
Ming Zhong
Independent Directorless than a yearno datano data

2.9yrs

Average Tenure

53yo

Average Age

Experienced Board: 600329's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.